Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:25944691

Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.

Jin-Soo Kim · Edward S Kim · Diane Liu · J Jack Lee · Carmen Behrens · Scott M Lippman · Waun Ki Hong · Ignacio I Wistuba · Euni Lee · Ho-Young Lee

Oncotarget · 2015 doi:10.18632/oncotarget.3796

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:25944691
kind
science-record
content_hash
sha256:3a525b5836b5d4dba998c9166375a58bbcbfb45bf386829c28203ef4fa938616
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:08Z
updated_at
2026-11-01T21:58:30Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.
doi
10.18632/oncotarget.3796
pmid
25944691
authors array · 10 items
[0]
Jin-Soo Kim
[1]
Edward S Kim
[2]
Diane Liu
[3]
J Jack Lee
[4]
Carmen Behrens
[5]
Scott M Lippman
[6]
Waun Ki Hong
[7]
Ignacio I Wistuba
[8]
Euni Lee
[9]
Ho-Young Lee
journal
Oncotarget
year
2015
abstract
According to previous reports demonstrating the implication of insulin-like growth factor receptor (IGF-1R) signaling in non-small cell lung cancer (NSCLC), in this study, the potential prognostic values of IGF-1R expression/activation were analyzed. The expression and activation of IGF-1R were evaluated in two tissue microarray (TMA) sets from NSCLC patients (N = 352 for TMA I, and N = 353 for TMA II). Alterations in IGF-1R protein or mRNA expression in NSCLC patients were evaluated using publicly available data from The Cancer Genome Atlas (TCGA). We found that membranous and cytoplasmic IGF-1R expressions were significantly associated with squamous cell carcinoma (SCC) in both of the TMAs. Analysis of the TCGA data revealed increased mRNA levels in NSCLC patients, which was significantly associated with reductions in overall survival (OS) (median survival 26.51 vs. 47.77 months, P = 0.017) and disease-free survival (median survival 17.44 vs. 37.65 months, P = 0.045) only in NSCLC patients with adenocarcinoma (ADC). These data suggest that IGF-1R is activated in patients with NSCLC, particularly those with SCC. IGF-1R mRNA expression is a potential prognostic factor in patients with NSCLC, especially those with ADC. Further studies are warranted to investigate the prognostic value of IGF-1R in NSCLC patients.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28].
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:25944691
locator
sections[12] "Statistical analysis" paragraph 2
quote
The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28].
state
complete
[1] object · 6 fields
id
claim-data-access
statement
We obtained archived formalin-fixed and paraffin-embedded samples from previously described tissue banks at The University of Texas M.D. Anderson Cancer Center (Houston, TX) [23]. The tissue specimens were originally collected between 1997 and 2005 and were classified using the 2004 World Health Organization classification system [25].
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:25944691
locator
sections[9] "Case selection and TMA construction" paragraph 2
quote
We obtained archived formalin-fixed and paraffin-embedded samples from previously described tissue banks at The University of Texas M.D. Anderson Cancer Center (Houston, TX) [23]. The tissue specimens were originally collected between 1997 and 2005 and were classified using the 2004 World Health Organization classification system [25].
state
complete
[2] object · 6 fields
id
claim-target-result
statement
In TCGA NSCLC data, increased IGF-1R mRNA expression was associated with shorter overall and disease-free survival in patients with adenocarcinoma.
kind
qualitative
target
null
evidence array · 3 items
[0] object · 3 fields
asset
source:pmid:25944691
locator
sections[0] "Abstract" paragraph 1
quote
Analysis of the TCGA data revealed increased mRNA levels in NSCLC patients, which was significantly associated with reductions in overall survival (OS) (median survival 26.51 vs. 47.77 months, P = 0.017) and disease-free survival (median survival 17.44 vs. 37.65 months, P = 0.045) only in NSCLC patients with adenocarcinoma (ADC).
[1] object · 3 fields
asset
source:pmid:25944691
locator
sections[12] "Statistical analysis" paragraph 2
quote
The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28].
[2] object · 3 fields
asset
source:pmid:25944691
locator
sections[11] "IGF-1R mRNA and protein expression and survival from The Cancer Genome Atlas (TCGA) data" paragraph 2
quote
The TCGA Research Network portal was used for evaluating alterations in mRNA and protein expression, and clinical data for comparing survival; these are available at www.cbioportal.org/public-portal [27, 28].
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
In TCGA NSCLC data, increased IGF-1R mRNA expression was associated with shorter overall and disease-free survival in patients with adenocarcinoma.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:25944691
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 5 items
[0] object · 15 fields
id
source:pmid:25944691
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.18632/oncotarget.3796
sha256
sha256:fbb57f174f56f7999902392bd7554848415f54f742246501bd21c328decbce03
bytes
20114
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.18632/oncotarget.3796
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC4599304
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 16 fields
id
asset:table:pmid:25944691:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:3060b50f2f8eb4e5a726083e5c724bc5c7a3933e43591c779886650af63cc910
bytes
1007
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[3]/table-wrap[1]#T1
version
null
note
Patients characteristics in tissue microarray (TMA) dataset I
structure object · 5 fields
pmcid
PMC4599304
section_index
3
section_title
Expression of IGF-1R and pIGF-1R
row_count
34
column_count
2
table object · 8 fields
label
Table 1
caption
Patients characteristics in tissue microarray (TMA) dataset I
rows array · 34 items
[0] array · 2 items
[0]
Characteristic
[1]
TMA I (N=352)
[1] array · 2 items
[0]
Median age
[1]
[2] array · 2 items
[0]
Years (Range)
[1]
66 (34-90)
[3] array · 2 items
[0]
Gender
[1]
[4] array · 2 items
[0]
Female
[1]
189 (53.7%)
[5] array · 2 items
[0]
Male
[1]
160 (45.5%)
[6] array · 2 items
[0]
Histology
[1]
[7] array · 2 items
[0]
Adenocarcinoma
[1]
231 (65.6%)
[8] array · 2 items
[0]
Squamous cell carcinoma
[1]
121 (34.3%)
[9] array · 2 items
[0]
Ethnicity
[1]
[10] array · 2 items
[0]
Caucasian
[1]
313 (88.9%)
[11] array · 2 items
[0]
Asian
[1]
14 (4.0%)
[12] array · 2 items
[0]
African American
[1]
15 (4.3%)
[13] array · 2 items
[0]
Hispanic
[1]
10 (2.8%)
[14] array · 2 items
[0]
Smoking status*
[1]
[15] array · 2 items
[0]
Never
[1]
63 (17.9%)
[16] array · 2 items
[0]
Former
[1]
174 (49.4%)
[17] array · 2 items
[0]
Current
[1]
114 (32.4%)
[18] array · 2 items
[0]
Unknown
[1]
1 (0.3%)
[19] array · 2 items
[0]
Pathological T stage†
[1]
[20] array · 2 items
[0]
T1
[1]
130 (36.9%)
[21] array · 2 items
[0]
T2
[1]
185 (52.6%)
[22] array · 2 items
[0]
T3
[1]
18 (5.1%)
[23] array · 2 items
[0]
T4
[1]
20 (5.7%)
[24] array · 2 items
[0]
Pathological N stage†
[1]
[25] array · 2 items
[0]
N0
[1]
253 (71.9%)
[26] array · 2 items
[0]
N1
[1]
60 (17.0%)
[27] array · 2 items
[0]
N2
[1]
39 (11.1%)
[28] array · 2 items
[0]
Nx
[1]
[29] array · 2 items
[0]
Final Stage†
[1]
[30] array · 2 items
[0]
I
[1]
225 (63.9%)
[31] array · 2 items
[0]
II
[1]
65 (18.5%)
[32] array · 2 items
[0]
III
[1]
50 (14.2%)
[33] array · 2 items
[0]
IV
[1]
12 (3.4%)
locator
section[3]/table-wrap[1]#T1
[2] object · 16 fields
id
asset:table:pmid:25944691:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:144a9dfcef2cadf9470bfc3c9ae15f800c18fd5947866da2f1b6b9f29c48db4b
bytes
1176
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[3]/table-wrap[2]#T2
version
null
note
Patients characteristics in tissue microarray (TMA) dataset II
structure object · 5 fields
pmcid
PMC4599304
section_index
3
section_title
Expression of IGF-1R and pIGF-1R
row_count
41
column_count
2
table object · 8 fields
label
Table 2
caption
Patients characteristics in tissue microarray (TMA) dataset II
rows array · 41 items
[0] array · 2 items
[0]
Characteristic
[1]
TMA II (N=353)
[1] array · 2 items
[0]
Median age
[1]
[2] array · 2 items
[0]
Years (Range)
[1]
66 (34-90)
[3] array · 2 items
[0]
Gender
[1]
[4] array · 2 items
[0]
Female
[1]
174 (49.3%)
[5] array · 2 items
[0]
Male
[1]
179 (50.7%)
[6] array · 2 items
[0]
Histology
[1]
[7] array · 2 items
[0]
Adenocarcinoma
[1]
227 (64.3%)
[8] array · 2 items
[0]
Squamous cell carcinoma
[1]
126 (35.7%)
[9] array · 2 items
[0]
Ethnicity
[1]
[10] array · 2 items
[0]
Caucasian
[1]
316 (89.5%)
[11] array · 2 items
[0]
Asian
[1]
5(1.4%)
[12] array · 2 items
[0]
African American
[1]
18 (5.1%)
[13] array · 2 items
[0]
Hispanic
[1]
14 (4%)
[14] array · 2 items
[0]
Smoking status*
[1]
[15] array · 2 items
[0]
Never
[1]
38 (10.8%)
[16] array · 2 items
[0]
Former
[1]
164 (46.5%)
[17] array · 2 items
[0]
Current
[1]
151 (42.8%)
[18] array · 2 items
[0]
Unknown
[1]
[19] array · 2 items
[0]
Pathological T stage†
[1]
[20] array · 2 items
[0]
T1
[1]
131(37.1%)
[21] array · 2 items
[0]
T2
[1]
202(57.2%)
[22] array · 2 items
[0]
T3
[1]
20(5.7%)
[23] array · 2 items
[0]
Pathological N stage†
[1]
[24] array · 2 items
[0]
N0
[1]
236 (67.6%)
[25] array · 2 items
[0]
N1
[1]
66 (18.9%)
[26] array · 2 items
[0]
N2
[1]
47 (13.5%)
[27] array · 2 items
[0]
Final Stage†
[1]
[28] array · 2 items
[0]
IA
[1]
100 (28.3%)
[29] array · 2 items
[0]
IB
[1]
125 (35.4%)
[30] array · 2 items
[0]
IIA
[1]
22 (6.2%)
[31] array · 2 items
[0]
IIB
[1]
49 (13.9%)
[32] array · 2 items
[0]
IIIA
[1]
57(16.1%)
[33] array · 2 items
[0]
Adjuvant treatment
[1]
[34] array · 2 items
[0]
No
[1]
216 (61.2%)
[35] array · 2 items
[0]
Yes
[1]
119 (33.7%)
[36] array · 2 items
[0]
Unknown
[1]
18 (5.1%)
[37] array · 2 items
[0]
Neoadjuvant treatment
[1]
[38] array · 2 items
[0]
No
[1]
298 (84.4%)
[39] array · 2 items
[0]
Yes
[1]
52 (14.7%)
[40] array · 2 items
[0]
Unknown
[1]
3 (0.8%)
locator
section[3]/table-wrap[2]#T2
[3] object · 16 fields
id
asset:table:pmid:25944691:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:4cd7fe4cf8369c77d19d58b109546654ab884a155410fd556f4902734c1235b6
bytes
1184
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[4]/table-wrap[1]#T3
version
null
note
Univariate analyses of clinical prognostic factors and biomarkers (TMA I)
structure object · 5 fields
pmcid
PMC4599304
section_index
4
section_title
Recurrence-free survival and overall survival
row_count
15
column_count
5
table object · 8 fields
label
Table 3
caption
Univariate analyses of clinical prognostic factors and biomarkers (TMA I)
rows array · 15 items
[0] array · 5 items
[0]
Variable
[1]
HR for OS (95% CI)
[2]
p-value
[3]
HR for RFS (95% CI)
[4]
p-value*
[1] array · 5 items
[0]
Age
[1]
.997 (.979-1.015)
[2]
.723
[3]
1.040 (1.025-1.056)
[4]
<.0001
[2] array · 5 items
[0]
Gender (M vs.F)
[1]
.813 (.549-1.203)
[2]
.300
[3]
1.324 (.981-1.786)
[4]
.066
[3] array · 5 items
[0]
Race (white vs. other)
[1]
2.123 (1.261-3.574)
[2]
.005
[3]
1.043 (.640-1.699)
[4]
.867
[4] array · 5 items
[0]
Smoker (Ever vs. never)
[1]
.669 (418-1.072)
[2]
.095
[3]
1.136 (.754-1.712)
[4]
.542
[5] array · 5 items
[0]
Histology (ADC vs. SCC)
[1]
.946 (.626-1.430)
[2]
.792
[3]
1.442 (1.068-1.949)
[4]
.017
[6] array · 5 items
[0]
Stage (vs. I)
[1]
[2]
[3]
[4]
[7] array · 5 items
[0]
II
[1]
2.005 (1.201-3346)
[2]
.008
[3]
1.566 (1.069-2.293)
[4]
.021
[8] array · 5 items
[0]
III/IV
[1]
4.106 (2.557-6.593)
[2]
<.001
[3]
2.707 (1.365-5.370)
[4]
.004
[9] array · 5 items
[0]
IGF-1R
[1]
[2]
[3]
[4]
[10] array · 5 items
[0]
cytoplasmic
[1]
.998 (.993-1.003)
[2]
.381
[3]
1.000 (.997-1.003)
[4]
.961
[11] array · 5 items
[0]
membrane
[1]
.995 (.988-1.003)
[2]
.238
[3]
1.000 (.995-1.005)
[4]
.962
[12] array · 5 items
[0]
p-IGF-IR/1R
[1]
[2]
[3]
[4]
[13] array · 5 items
[0]
cytoplasmic
[1]
1.008 (.987-1.030)
[2]
.444
[3]
1.011 (.996-1.026)
[4]
.141
[14] array · 5 items
[0]
membrane
[1]
1.004 (.999-1.009)
[2]
.157
[3]
1.004 (.999-1.008)
[4]
.099
locator
section[4]/table-wrap[1]#T3
[4] object · 16 fields
id
asset:table:pmid:25944691:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:54f335ffb77a4b2623f3e5ff5d4945af406889623ab11142163ae5a4803fdf48
bytes
1312
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[4]/table-wrap[2]#T4
version
null
note
Univariate analyses of clinical prognostic factors and biomarkers (TMA II)
structure object · 5 fields
pmcid
PMC4599304
section_index
4
section_title
Recurrence-free survival and overall survival
row_count
17
column_count
5
table object · 8 fields
label
Table 4
caption
Univariate analyses of clinical prognostic factors and biomarkers (TMA II)
rows array · 17 items
[0] array · 5 items
[0]
Variable
[1]
HR for OS (95% CI)
[2]
p-value
[3]
HR for RFS (95% CI)
[4]
p-value*
[1] array · 5 items
[0]
Age
[1]
1.015 (0.998-1.031)
[2]
0.08
[3]
1.007 (0.993-1.022)
[4]
0.31
[2] array · 5 items
[0]
Gender (M vs.F)
[1]
1.468 (1.067-2.020)
[2]
0.0186
[3]
1.317 (0.997-1.740)
[4]
0.053
[3] array · 5 items
[0]
Race (white vs. other)
[1]
0.747 (0.457-1.222)
[2]
0.245
[3]
0.784 (0.504-1.222)
[4]
0.28
[4] array · 5 items
[0]
Smoker
[1]
[2]
[3]
[4]
[5] array · 5 items
[0]
Former vs. Never
[1]
1.045 (0.597-1.828)
[2]
0.88
[3]
1.081 (0.667-1.751)
[4]
0.75
[6] array · 5 items
[0]
Current vs. Never
[1]
1.219 (0.698-2.129)
[2]
0.49
[3]
1.108 (0.681-1.803)
[4]
0.68
[7] array · 5 items
[0]
Histology (ADC vs. SCC)
[1]
0.831 (0.600-1.151)
[2]
0.27
[3]
0.809 (0.609-1.074)
[4]
0.14
[8] array · 5 items
[0]
Stage (vs. I)
[1]
[2]
[3]
[4]
[9] array · 5 items
[0]
II
[1]
1.608 (1.090-2.374)
[2]
0.0157
[3]
1.73 (1.226-2.440)
[4]
0.0018
[10] array · 5 items
[0]
IIIA
[1]
2.399 (1.613-3.570)
[2]
<0.0001
[3]
2.734 (1.930-3.872)
[4]
<0.0001
[11] array · 5 items
[0]
IGF-IR
[1]
[2]
[3]
[4]
[12] array · 5 items
[0]
cytoplasmic
[1]
1.003 (0.999-1.007)
[2]
0.19
[3]
1.004 (1.000-1.008)
[4]
0.034
[13] array · 5 items
[0]
membrane
[1]
1.002 (0.992-1.011)
[2]
0.70
[3]
1.001 (0.992-1.010)
[4]
0.88
[14] array · 5 items
[0]
p-IGF-112/IR
[1]
[2]
[3]
[4]
[15] array · 5 items
[0]
cytoplasmic
[1]
0.997 (0.985-1.010)
[2]
0.50
[3]
0.990 (0.978-1.003)
[4]
0.12
[16] array · 5 items
[0]
membrane
[1]
0.998 (0.993-1.003)
[2]
0.41
[3]
0.997 0.992-1.001
[4]
0.16
locator
section[4]/table-wrap[2]#T4
gaps array · 0 items
analysis object · 4 fields
state
partial
methods array · 2 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28].
[1] object · 10 fields
id
method-2
family
group_comparison
specific
wilcoxon
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
Wilcoxon
targets array · 0 items
gaps array · 1 item
[0]
method.reader_differs_from_extractor
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: log_rank_test.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 0 items
resolved_accessions array · 0 items
statements array · 1 item
[0]
We obtained archived formalin-fixed and paraffin-embedded samples from previously described tissue banks at The University of Texas M.D. Anderson Cancer Center (Houston, TX) [23]. The tissue specimens were originally collected between 1997 and 2005 and were classified using the 2004 World Health Organization classification system [25].
basis
The paper names no accession to its source data, so the data has to come from the authors.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
logrank_test
assets array · 5 items
[0]
source:pmid:25944691
[1]
asset:table:pmid:25944691:1
[2]
asset:table:pmid:25944691:2
[3]
asset:table:pmid:25944691:3
[4]
asset:table:pmid:25944691:4
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:23:53Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
null
calls
8
usage object · 3 fields
prompt_tokens
41205
completion_tokens
4839
cached_tokens
10784
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:25944691
type
paper
label
pmid:25944691
[1] object · 3 fields
id
source:pmid:25944691
type
manuscript
label
PMID 25944691 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:25944691
type
paper
label
pmid:25944691
[1] object · 3 fields
id
source:pmid:25944691
type
manuscript
label
PMID 25944691 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-25944691
type
extraction
used array · 1 item
[0]
source:pmid:25944691
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:25944691
parent_hash
sha256:f4366c58dacbb9528c55eac732e6904d66f27572cbf4446dada8b7c54ed5fe61
fork_of
null
gaps array · 6 items
[0]
execution.not_run
[1]
method.reader_differs_from_extractor
[2]
review.human_critique
[3]
review.independent_reader
[4]
review.machine_critique
[5]
step:obtain_source_data blocked on data:accession_absent
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
microarray
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
ation of IGF-1R were evaluated in two tissue microarray (TMA) sets from NSCLC patients (N = 352 for
[1]
baseline characteristics from the two tissue microarray (TMA) sets are presented in Tables 1 and 2.
order_basis
paper_text_order:372
id
assay:1
[1] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
logrank_test
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28].
order_basis
consumes_earlier_output
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:25944691", "kind": "science-record", "revision": 7, "content_hash": "sha256:3a525b5836b5d4dba998c9166375a58bbcbfb45bf386829c28203ef4fa938616", "created_at": "2026-11-01T15:40:08Z", "updated_at": "2026-11-01T21:58:30Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.", "doi": "10.18632/oncotarget.3796", "pmid": "25944691", "authors": ["Jin-Soo Kim", "Edward S Kim", "Diane Liu", "J Jack Lee", "Carmen Behrens", "Scott M Lippman", "Waun Ki Hong", "Ignacio I Wistuba", "Euni Lee", "Ho-Young Lee"], "journal": "Oncotarget", "year": 2015, "abstract": "According to previous reports demonstrating the implication of insulin-like growth factor receptor (IGF-1R) signaling in non-small cell lung cancer (NSCLC), in this study, the potential prognostic values of IGF-1R expression/activation were analyzed. The expression and activation of IGF-1R were evaluated in two tissue microarray (TMA) sets from NSCLC patients (N = 352 for TMA I, and N = 353 for TMA II). Alterations in IGF-1R protein or mRNA expression in NSCLC patients were evaluated using publicly available data from The Cancer Genome Atlas (TCGA). We found that membranous and cytoplasmic IGF-1R expressions were significantly associated with squamous cell carcinoma (SCC) in both of the TMAs. Analysis of the TCGA data revealed increased mRNA levels in NSCLC patients, which was significantly associated with reductions in overall survival (OS) (median survival 26.51 vs. 47.77 months, P = 0.017) and disease-free survival (median survival 17.44 vs. 37.65 months, P = 0.045) only in NSCLC patients with adenocarcinoma (ADC). These data suggest that IGF-1R is activated in patients with NSCLC, particularly those with SCC. IGF-1R mRNA expression is a potential prognostic factor in patients with NSCLC, especially those with ADC. Further studies are warranted to investigate the prognostic value of IGF-1R in NSCLC patients.", "claims": [{"id": "claim-method", "statement": "The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28].", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:25944691", "locator": "sections[12] \"Statistical analysis\" paragraph 2", "quote": "The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28]."}], "state": "complete"}, {"id": "claim-data-access", "statement": "We obtained archived formalin-fixed and paraffin-embedded samples from previously described tissue banks at The University of Texas M.D. Anderson Cancer Center (Houston, TX) [23]. The tissue specimens were originally collected between 1997 and 2005 and were classified using the 2004 World Health Organization classification system [25].", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:25944691", "locator": "sections[9] \"Case selection and TMA construction\" paragraph 2", "quote": "We obtained archived formalin-fixed and paraffin-embedded samples from previously described tissue banks at The University of Texas M.D. Anderson Cancer Center (Houston, TX) [23]. The tissue specimens were originally collected between 1997 and 2005 and were classified using the 2004 World Health Organization classification system [25]."}], "state": "complete"}, {"id": "claim-target-result", "statement": "In TCGA NSCLC data, increased IGF-1R mRNA expression was associated with shorter overall and disease-free survival in patients with adenocarcinoma.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:25944691", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "Analysis of the TCGA data revealed increased mRNA levels in NSCLC patients, which was significantly associated with reductions in overall survival (OS) (median survival 26.51 vs. 47.77 months, P = 0.017) and disease-free survival (median survival 17.44 vs. 37.65 months, P = 0.045) only in NSCLC patients with adenocarcinoma (ADC)."}, {"asset": "source:pmid:25944691", "locator": "sections[12] \"Statistical analysis\" paragraph 2", "quote": "The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28]."}, {"asset": "source:pmid:25944691", "locator": "sections[11] \"IGF-1R mRNA and protein expression and survival from The Cancer Genome Atlas (TCGA) data\" paragraph 2", "quote": "The TCGA Research Network portal was used for evaluating alterations in mRNA and protein expression, and clinical data for comparing survival; these are available at www.cbioportal.org/public-portal [27, 28]."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "In TCGA NSCLC data, increased IGF-1R mRNA expression was associated with shorter overall and disease-free survival in patients with adenocarcinoma.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:25944691"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:25944691", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.18632/oncotarget.3796", "sha256": "sha256:fbb57f174f56f7999902392bd7554848415f54f742246501bd21c328decbce03", "bytes": 20114, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.18632/oncotarget.3796", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC4599304", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "asset:table:pmid:25944691:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:3060b50f2f8eb4e5a726083e5c724bc5c7a3933e43591c779886650af63cc910", "bytes": 1007, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[3]/table-wrap[1]#T1", "version": null, "note": "Patients characteristics in tissue microarray (TMA) dataset I", "structure": {"pmcid": "PMC4599304", "section_index": 3, "section_title": "Expression of IGF-1R and pIGF-1R", "row_count": 34, "column_count": 2}, "table": {"label": "Table 1", "caption": "Patients characteristics in tissue microarray (TMA) dataset I", "rows": [["Characteristic", "TMA I (N=352)"], ["Median age", ""], ["Years (Range)", "66 (34-90)"], ["Gender", ""], ["Female", "189 (53.7%)"], ["Male", "160 (45.5%)"], ["Histology", ""], ["Adenocarcinoma", "231 (65.6%)"], ["Squamous cell carcinoma", "121 (34.3%)"], ["Ethnicity", ""], ["Caucasian", "313 (88.9%)"], ["Asian", "14 (4.0%)"], ["African American", "15 (4.3%)"], ["Hispanic", "10 (2.8%)"], ["Smoking status*", ""], ["Never", "63 (17.9%)"], ["Former", "174 (49.4%)"], ["Current", "114 (32.4%)"], ["Unknown", "1 (0.3%)"], ["Pathological T stage†", ""], ["T1", "130 (36.9%)"], ["T2", "185 (52.6%)"], ["T3", "18 (5.1%)"], ["T4", "20 (5.7%)"], ["Pathological N stage†", ""], ["N0", "253 (71.9%)"], ["N1", "60 (17.0%)"], ["N2", "39 (11.1%)"], ["Nx", ""], ["Final Stage†", ""], ["I", "225 (63.9%)"], ["II", "65 (18.5%)"], ["III", "50 (14.2%)"], ["IV", "12 (3.4%)"]], "row_count": 34, "column_count": 2, "numeric_cells": 25, "header_rows": 1, "locator": "section[3]/table-wrap[1]#T1"}}, {"id": "asset:table:pmid:25944691:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:144a9dfcef2cadf9470bfc3c9ae15f800c18fd5947866da2f1b6b9f29c48db4b", "bytes": 1176, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[3]/table-wrap[2]#T2", "version": null, "note": "Patients characteristics in tissue microarray (TMA) dataset II", "structure": {"pmcid": "PMC4599304", "section_index": 3, "section_title": "Expression of IGF-1R and pIGF-1R", "row_count": 41, "column_count": 2}, "table": {"label": "Table 2", "caption": "Patients characteristics in tissue microarray (TMA) dataset II", "rows": [["Characteristic", "TMA II (N=353)"], ["Median age", ""], ["Years (Range)", "66 (34-90)"], ["Gender", ""], ["Female", "174 (49.3%)"], ["Male", "179 (50.7%)"], ["Histology", ""], ["Adenocarcinoma", "227 (64.3%)"], ["Squamous cell carcinoma", "126 (35.7%)"], ["Ethnicity", ""], ["Caucasian", "316 (89.5%)"], ["Asian", "5(1.4%)"], ["African American", "18 (5.1%)"], ["Hispanic", "14 (4%)"], ["Smoking status*", ""], ["Never", "38 (10.8%)"], ["Former", "164 (46.5%)"], ["Current", "151 (42.8%)"], ["Unknown", ""], ["Pathological T stage†", ""], ["T1", "131(37.1%)"], ["T2", "202(57.2%)"], ["T3", "20(5.7%)"], ["Pathological N stage†", ""], ["N0", "236 (67.6%)"], ["N1", "66 (18.9%)"], ["N2", "47 (13.5%)"], ["Final Stage†", ""], ["IA", "100 (28.3%)"], ["IB", "125 (35.4%)"], ["IIA", "22 (6.2%)"], ["IIB", "49 (13.9%)"], ["IIIA", "57(16.1%)"], ["Adjuvant treatment", ""], ["No", "216 (61.2%)"], ["Yes", "119 (33.7%)"], ["Unknown", "18 (5.1%)"], ["Neoadjuvant treatment", ""], ["No", "298 (84.4%)"], ["Yes", "52 (14.7%)"], ["Unknown", "3 (0.8%)"]], "row_count": 41, "column_count": 2, "numeric_cells": 30, "header_rows": 1, "locator": "section[3]/table-wrap[2]#T2"}}, {"id": "asset:table:pmid:25944691:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:4cd7fe4cf8369c77d19d58b109546654ab884a155410fd556f4902734c1235b6", "bytes": 1184, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[4]/table-wrap[1]#T3", "version": null, "note": "Univariate analyses of clinical prognostic factors and biomarkers (TMA I)", "structure": {"pmcid": "PMC4599304", "section_index": 4, "section_title": "Recurrence-free survival and overall survival", "row_count": 15, "column_count": 5}, "table": {"label": "Table 3", "caption": "Univariate analyses of clinical prognostic factors and biomarkers (TMA I)", "rows": [["Variable", "HR for OS (95% CI)", "p-value", "HR for RFS (95% CI)", "p-value*"], ["Age", ".997 (.979-1.015)", ".723", "1.040 (1.025-1.056)", "<.0001"], ["Gender (M vs.F)", ".813 (.549-1.203)", ".300", "1.324 (.981-1.786)", ".066"], ["Race (white vs. other)", "2.123 (1.261-3.574)", ".005", "1.043 (.640-1.699)", ".867"], ["Smoker (Ever vs. never)", ".669 (418-1.072)", ".095", "1.136 (.754-1.712)", ".542"], ["Histology (ADC vs. SCC)", ".946 (.626-1.430)", ".792", "1.442 (1.068-1.949)", ".017"], ["Stage (vs. I)", "", "", "", ""], ["II", "2.005 (1.201-3346)", ".008", "1.566 (1.069-2.293)", ".021"], ["III/IV", "4.106 (2.557-6.593)", "<.001", "2.707 (1.365-5.370)", ".004"], ["IGF-1R", "", "", "", ""], ["cytoplasmic", ".998 (.993-1.003)", ".381", "1.000 (.997-1.003)", ".961"], ["membrane", ".995 (.988-1.003)", ".238", "1.000 (.995-1.005)", ".962"], ["p-IGF-IR/1R", "", "", "", ""], ["cytoplasmic", "1.008 (.987-1.030)", ".444", "1.011 (.996-1.026)", ".141"], ["membrane", "1.004 (.999-1.009)", ".157", "1.004 (.999-1.008)", ".099"]], "row_count": 15, "column_count": 5, "numeric_cells": 48, "header_rows": 1, "locator": "section[4]/table-wrap[1]#T3"}}, {"id": "asset:table:pmid:25944691:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:54f335ffb77a4b2623f3e5ff5d4945af406889623ab11142163ae5a4803fdf48", "bytes": 1312, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[4]/table-wrap[2]#T4", "version": null, "note": "Univariate analyses of clinical prognostic factors and biomarkers (TMA II)", "structure": {"pmcid": "PMC4599304", "section_index": 4, "section_title": "Recurrence-free survival and overall survival", "row_count": 17, "column_count": 5}, "table": {"label": "Table 4", "caption": "Univariate analyses of clinical prognostic factors and biomarkers (TMA II)", "rows": [["Variable", "HR for OS (95% CI)", "p-value", "HR for RFS (95% CI)", "p-value*"], ["Age", "1.015 (0.998-1.031)", "0.08", "1.007 (0.993-1.022)", "0.31"], ["Gender (M vs.F)", "1.468 (1.067-2.020)", "0.0186", "1.317 (0.997-1.740)", "0.053"], ["Race (white vs. other)", "0.747 (0.457-1.222)", "0.245", "0.784 (0.504-1.222)", "0.28"], ["Smoker", "", "", "", ""], ["Former vs. Never", "1.045 (0.597-1.828)", "0.88", "1.081 (0.667-1.751)", "0.75"], ["Current vs. Never", "1.219 (0.698-2.129)", "0.49", "1.108 (0.681-1.803)", "0.68"], ["Histology (ADC vs. SCC)", "0.831 (0.600-1.151)", "0.27", "0.809 (0.609-1.074)", "0.14"], ["Stage (vs. I)", "", "", "", ""], ["II", "1.608 (1.090-2.374)", "0.0157", "1.73 (1.226-2.440)", "0.0018"], ["IIIA", "2.399 (1.613-3.570)", "<0.0001", "2.734 (1.930-3.872)", "<0.0001"], ["IGF-IR", "", "", "", ""], ["cytoplasmic", "1.003 (0.999-1.007)", "0.19", "1.004 (1.000-1.008)", "0.034"], ["membrane", "1.002 (0.992-1.011)", "0.70", "1.001 (0.992-1.010)", "0.88"], ["p-IGF-112/IR", "", "", "", ""], ["cytoplasmic", "0.997 (0.985-1.010)", "0.50", "0.990 (0.978-1.003)", "0.12"], ["membrane", "0.998 (0.993-1.003)", "0.41", "0.997 0.992-1.001", "0.16"]], "row_count": 17, "column_count": 5, "numeric_cells": 51, "header_rows": 1, "locator": "section[4]/table-wrap[2]#T4"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28]."}}, {"id": "method-2", "family": "group_comparison", "specific": "wilcoxon", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Wilcoxon"}}], "targets": [], "gaps": ["method.reader_differs_from_extractor"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["logrank_test"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: log_rank_test."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["We obtained archived formalin-fixed and paraffin-embedded samples from previously described tissue banks at The University of Texas M.D. Anderson Cancer Center (Houston, TX) [23]. The tissue specimens were originally collected between 1997 and 2005 and were classified using the 2004 World Health Organization classification system [25]."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": ["logrank_test"], "assets": ["source:pmid:25944691", "asset:table:pmid:25944691:1", "asset:table:pmid:25944691:2", "asset:table:pmid:25944691:3", "asset:table:pmid:25944691:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:23:53Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 8, "usage": {"prompt_tokens": 41205, "completion_tokens": 4839, "cached_tokens": 10784}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:25944691", "type": "paper", "label": "pmid:25944691"}, {"id": "source:pmid:25944691", "type": "manuscript", "label": "PMID 25944691 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:25944691", "type": "paper", "label": "pmid:25944691"}, {"id": "source:pmid:25944691", "type": "manuscript", "label": "PMID 25944691 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-25944691", "type": "extraction", "used": ["source:pmid:25944691"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:25944691", "parent_hash": "sha256:f4366c58dacbb9528c55eac732e6904d66f27572cbf4446dada8b7c54ed5fe61", "fork_of": null, "generation": 6}, "gaps": ["execution.not_run", "method.reader_differs_from_extractor", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ation of IGF-1R were evaluated in two tissue microarray (TMA) sets from NSCLC patients (N = 352 for", "baseline characteristics from the two tissue microarray (TMA) sets are presented in Tables 1 and 2."], "order_basis": "paper_text_order:372", "id": "assay:1"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["logrank_test"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["The association between changes in IGF-1R mRNA expression and OS or DFS was evaluated by a log-rank test and provided by the TCGA Research Network [27, 28]."], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}